Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Sohini Das leads the automobile and healthcare verticals at Business Standard. In her 17 years as a journalist, she has written on myriad subjects and sectors -- FMCG, dairies, tourism, and state elections, among others, across Kolkata, Ahmedabad and now Mumbai. She loves doing personality stories and ground reportage.
Page 53 - Sohini Das
Podcast: Will Viatris deal inject fresh momentum into Biocon biz?
Sohini Das caught up with Biocon Biologics CEO Shreehas Tambe to know more about the deal and the company's future plans
 "Podcast: Will Viatris deal inject fresh momentum into Biocon biz?")
Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA
The USFDA had imposed an import ban on the Halol plant in December 2015 too
 "Sun Pharmaceuticals' Halol plant gets 'import alert' from USFDA")
Pharma logs 17% growth in Nov; anti-infective therapy drives market demand
Key antibiotic brands like Augmentin (GSK) and Clavam (Alkem) clocked 25 per cent and 29 percent growth, respectively, in November, the data showed
 "Pharma logs 17% growth in Nov; anti-infective therapy drives market demand")
Innovator drugs maintain market hold even after patent expiry, shows data
Merck's anti-diabetic molecule sitagliptin retains 81% market share in value terms
 "Innovator drugs maintain market hold even after patent expiry, shows data")
Local medical device makers seek trade margin rationalisation in Budget 23
Group wants basic custom duty on import of medical devices increased to 10-15%
 "Local medical device makers seek trade margin rationalisation in Budget 23")
Viatris deal gives Biocon Biologics entry in 100 countries: Shreehas Tambe
In a Q&A, the recently named MD & CEO of Biocon Biologics dwells on the scope for an IPO or stake sale to PE investors to retire the debt taken to fund the acquisition
Price war begins for Novartis cardiac drug as JB Pharma cuts rate by 50%
Novartis' blockbuster drug is set to lose patent in Jan; JB Pharma, one of the four marketers in India of generi versions, has slashed the price of its brand Azmarda to Rs 39.6 a tablet
 "Price war begins for Novartis cardiac drug as JB Pharma cuts rate by 50%")
Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday
He was earlier the firm's deputy CEO; Outgoing MD Arun Chandavarkar to remain on co Board
 "Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday")
Lessons from Covid: Pharma firms turn attention to adult vaccination
Vaccine companies have warmed up to the idea of adult vaccines for other diseases such as pneumonia, flu and shingles as well
 "Lessons from Covid: Pharma firms turn attention to adult vaccination")
After the anti-diabetic market, India's cardiac market in for a shake-up
Sun Pharma has the largest share in the Indian cardiac market, followed by Torrent Pharma, Lupin and USV
Pharma, consumer durables sectors likely to feel China curb heat
Industry players say lockdown could have an impact on the supply of components used in consumer durables
Flu season starts, but demand for cough-cold meds remains weak
Impact in US among the worst in the past 10 years
With the flu season here, should you ask for an influenza vaccine?
Demand for flu vaccine weak in India; US facing worst season in a decade
 "With the flu season here, should you ask for an influenza vaccine?")
State govts on overdrive to vaccinate as measles outbreaks spread
Outbreaks have been reported in several states including Maharashtra, Kerala, Bihar, Jharkhand, Gujarat and Haryana
 "State govts on overdrive to vaccinate as measles outbreaks spread")
Gland Pharma to acquire French firm Cenexi Group for Rs 1,000 crore
Will fund transaction from internal accruals
 "Gland Pharma to acquire French firm Cenexi Group for Rs 1,000 crore")
Bharat Bio looks for partners to manufacture, distribute iNCOVACC globally
Its local production ramp-up remains unhurried as demand for boosters reduces
 "Bharat Bio looks for partners to manufacture, distribute iNCOVACC globally")
Bharat Biotech gets nasal vaccine nod for use as mix-match booster
iNCOVACC first intranasal Covid shot to receive approval for primary 2-dose schedule, heterologous booster us
 "Bharat Biotech gets nasal vaccine nod for use as mix-match booster")
China-Plus-One strategy: Indian API firms start to reap benefits
Rising Chinese labour costs, geopolitics, pandemic-stricken uncertainties have forced global players to derisk
 "China-Plus-One strategy: Indian API firms start to reap benefits")
As China intensifies Covid restrictions, India begins to relax curbs
Data shows that spike in one country has not coincided with a rise in the other
 "As China intensifies Covid restrictions, India begins to relax curbs")
Zuventus first in world to launch aviptadil for ARDS commercially
Discovered in 1970, the drug was tested on severe Covid-19 patients on DCGI's direction
 "Zuventus first in world to launch aviptadil for ARDS commercially")
